Medication CostsMay 28, 2026

Eliquis vs. Warfarin: Why Patients Switch — and Why Cost Becomes the Problem

Millions of patients switched from warfarin to Eliquis for good clinical reasons. But the cost difference is dramatic. Here's what to know and what to do if you can't afford Eliquis.

Written by

J

Jacob Elich

Health Consulting & Business Operations

Jacob Elich is the founder of ClariMeds and an MBA-trained business operator with a background in health consulting and dealmaking. He started ClariMeds after watching family members struggle to afford medications they were prescribed but couldn't pay for — and realizing that the manufacturer assistance programs that could have helped them were largely invisible to the people who needed them most. His work focuses on closing that gap.

Eliquis vs. Warfarin: Why Patients Switch — and Why Cost Becomes the Problem

For decades, warfarin was the standard anticoagulant for patients with atrial fibrillation, blood clots, and other conditions requiring long-term blood thinning. Then came the newer direct oral anticoagulants — Eliquis, Xarelto, Pradaxa — and prescribing patterns shifted significantly.

Eliquis became the most prescribed anticoagulant in the U.S. The clinical reasons are real. But so is the cost shock many patients experience when they transition from a $4/month generic to a $600+/month brand.

Why Doctors Prefer Eliquis Over Warfarin

Warfarin works, but managing it is complicated:

  • Frequent monitoring required. Patients on warfarin need regular INR blood tests to ensure the drug is within the therapeutic range.
  • Dietary restrictions. Vitamin K (found in leafy greens, many vegetables) can interfere with warfarin's effectiveness. Patients must maintain consistent vitamin K intake.
  • Drug interactions. Warfarin interacts with dozens of medications, including common antibiotics, NSAIDs, and supplements.
  • Narrow therapeutic window. Too little warfarin means inadequate protection; too much increases bleeding risk significantly.

Eliquis (apixaban) addresses most of these issues:

  • No routine monitoring required
  • No dietary restrictions
  • Fewer significant drug interactions
  • Predictable dosing

Clinical trials showed Eliquis was at least as effective as warfarin for stroke prevention in AFib, with a better bleeding profile — particularly for intracranial (brain) bleeds, which are the most feared warfarin complication.

The Cost Difference

| Medication | Monthly Cost Without Insurance | |-----------|-------------------------------| | Warfarin (generic) | $4–$12 | | Eliquis (brand) | $550–$700 | | Generic apixaban | $40–$120 (varies widely) |

This is a 50–100x cost difference. For patients on fixed incomes — especially seniors on Medicare — this gap can mean choosing between medication and other necessities.

Can You Switch Back to Warfarin?

Clinically, yes — some patients do switch back to warfarin, particularly when they cannot afford Eliquis and have no assistance options.

Whether this is right for you is a conversation to have with your doctor. Some patients are on Eliquis specifically because they had complications on warfarin, or because their lifestyle makes INR monitoring impractical. Switching back carries real clinical considerations that vary by patient.

Never stop an anticoagulant or switch medications without medical supervision. The risks of unmanaged atrial fibrillation include stroke.

Can You Use Generic Apixaban?

Generic apixaban (the active ingredient in Eliquis) became available in the U.S. in late 2023 through patent settlement agreements with several generic manufacturers. It contains the same drug at the same doses.

Availability and pricing vary. At some pharmacies with GoodRx or similar discount programs, generic apixaban can cost $40–$120/month — significantly less than brand Eliquis.

However:

  • Not all insurance plans cover the generic the same way they cover brand Eliquis
  • Not all pharmacies stock it consistently
  • Your plan may require a prior authorization for the switch

Ask your doctor about writing the prescription as "apixaban" rather than "Eliquis" to allow generic substitution.

Assistance Programs for Eliquis

Before switching medications for cost reasons, explore whether financial assistance is available for Eliquis:

BMS Access Support provides free Eliquis to uninsured and underinsured patients who meet income guidelines. Many patients who think they "won't qualify" actually do.

Eliquis copay card reduces costs to as low as $10/month for patients with commercial (non-Medicare) insurance.

Medicare Extra Help can reduce Eliquis costs dramatically for Medicare beneficiaries with limited incomes.

ClariMeds helps patients identify and apply for whichever program fits their situation. Apply here — a real person reviews every case.

The Bottom Line

The clinical case for Eliquis over warfarin is legitimate. But cost is a real barrier, and cost-driven medication non-adherence is itself a serious health risk.

If you've been switched to Eliquis and can't afford it, the answer isn't necessarily to switch back — it's to find assistance. The programs exist. The challenge is navigating them.

Paying too much for your medication?

ClariMeds connects you to free or low-cost medications through manufacturer assistance programs — and handles every step of the application for you.

See If You Qualify — Free
← Back to all articles